Pasanting, Joseph Marih B.
HRN: 12-68-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2024
CEFUROXIME 750MG (VIAL)
06/16/2024
06/22/2024
IV
750mg
Q8h
Complicated Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes